checkAd

     189  0 Kommentare Axsome Therapeutics to Report First Quarter 2024 Financial Results on May 6 - Seite 2

    Axsome Contacts:

    Investors:
    Mark Jacobson
    Chief Operating Officer
    Axsome Therapeutics, Inc.
    One World Trade Center, 22nd Floor
    New York, NY 10007
    Tel: 212-332-3243
    Email: mjacobson@axsome.com
    www.axsome.com

    Lesen Sie auch

    Media:
    Darren Opland
    Director, Corporate Communications
    Axsome Therapeutics, Inc.
    One World Trade Center, 22nd Floor
    New York, NY 10007
    Tel: 929-837-1065
    Email: dopland@axsome.com
    www.axsome.com



    globenewswire
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors

    Seite 2 von 2

    Verfasst von globenewswire
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    Axsome Therapeutics to Report First Quarter 2024 Financial Results on May 6 - Seite 2 NEW YORK, April 10, 2024 (GLOBE NEWSWIRE) - Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders, today announced it will …